A Phase II, single-arm clinical trial of administration of cisplatin and 5-fluorouracil with afatinib as first-line therapy in patients with inoperable gastric or gastroesophageal junction cancer
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Afatinib (Primary) ; Cisplatin (Primary) ; Fluorouracil (Primary)
- Indications Adenocarcinoma; Carcinoma; Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- Acronyms A-GAPP
- 30 Aug 2019 Status changed from active, no longer recruiting to completed.
- 10 May 2019 Planned primary completion date changed from 1 Mar 2019 to 1 May 2019.
- 21 Feb 2019 Planned primary completion date changed from 1 Dec 2018 to 1 Mar 2019.